Skip to main content

Month: May 2021

Proactive news headlines including Esports Entertainment Group, Unigold, ElectraMeccanica Vehicles Corp and Bam Bam Resources

New York , May 14, 2021 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies:Esports Entertainment Group Inc (NASDAQ:GMBL) says subsidiaries link up with Riot Games to host LCS Proving Grounds League of Legends tournament says subsidiaries link up with Riot Games to host LCS Proving Grounds League of Legends tournament click here Elys Game Technology Corp (NASDAQ:ELYS) (NEO:ELYS) sees 1Q revenue climb by 39% to $14.2M on record wager turnover click here Unigold Inc (CVE:UGD) (OTCQX:UGDIF) (FRA:UGB1) adds 200,000 gold ounces to its Candelones project in newly released resource estimate click here NexTech AR Solutions Corp (OTCQB:NEXCF) (NEO:NTAR) (CSE:NTAR) (FRA:N29) partners with Visit Tampa Bay to use augmented reality...

Continue reading

IntelGenx Announces Initial Closing of atai Investment

SAINT LAURENT, Quebec, May 14, 2021 (GLOBE NEWSWIRE) — IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today reported that the previously announced US$12,346,300 investment in IntelGenx by ATAI Life Sciences AG (“atai”) has been completed. As a result of the investment, atai now holds approximately 25% of the issued and outstanding common stock of IntelGenx. “We would again like to thank our shareholders for their support of our transformative strategic partnership with atai,” said Dr. Horst G. Zerbe, CEO of IntelGenx. “In addition to positioning IntelGenx as a leader within the novel therapeutics field of psychedelics, atai’s investment provides us with the requisite financial resources to continue to advance our portfolio of other pharmaceutical film product candidates...

Continue reading

Qualigen Therapeutics, Inc. Reports First Quarter 2021 Financial Results and Provides Corporate Update

Conference call scheduled for May 18, 2021 at 4:10 p.m. EDT.Revenues Increased 30 Percent to $1.9 Million Compared to $1.5 Million in the Same Quarter of the Previous Year On Track to File an IND in 2H21 for Treating Hospitalized COVID-19 Patients with QN-165 Completed the R&D Evaluation and Qualification for QN-247; Expect to Finalize Formulation in 2H21 Quarter-End Cash and Cash Equivalents Approximately $21.9 Million; Provides Sufficient Runway to Accomplish Key Inflection PointsCARLSBAD, Calif., May 14, 2021 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a biotechnology company focused on developing novel therapeutics for the treatment of cancer and viral diseases, today announced its financial results for the quarter ended March 31, 2021, and provided an update on its therapeutics pipeline and other...

Continue reading

Nasdaq Announces 2021 Annual Meeting of Shareholders

Nasdaq’s 2021 Annual Meeting of ShareholdersNasdaq, Inc. has scheduled its 2021 Annual Meeting of Shareholders for June 15, 2021 at 9:00 AM ET.NEW YORK, May 14, 2021 (GLOBE NEWSWIRE) — Nasdaq, Inc. (Nasdaq: NDAQ) has scheduled its 2021 Annual Meeting of Shareholders for June 15, 2021 at 9:00 AM ET. Shareholders of record will be able to vote and ask questions online during the meeting. The virtual meeting website will be accessible 15 minutes prior to the meeting start by visiting: www.virtualshareholdermeeting.com/NDAQ2021. The record date for determining shareholders entitled to participate at the Annual Meeting was April 19, 2021. Nasdaq’s 2021 Proxy Statement and 2020 Annual Report on Form 10-K are available at www.nasdaq.com/annual-meeting. The Proxy Statement contains information on voting and admission...

Continue reading

Specialty Ink Developer Nocopi Q1 Revenue Grows 18% to $0.6M and Net Income Doubles to $114,800 and Cash Rises $0.4M to $1.7M vs Year-End 2020

KING OF PRUSSIA, Pa., May 14, 2021 (GLOBE NEWSWIRE) — Nocopi Technologies, Inc. (OTC Pink: NNUP), a developer of specialty reactive inks used in entertainment, toy and educational products as well as in document and product authentication technologies to combat fraud, today announced results for its first quarter ended March 31, 2021 (Q1’21). Nocopi’s SEC filings are available here. Q1 HighlightsRevenue rose 18% to $611,400, driven by a 20% increase in product sales Gross profit increased 45% to $391,000 due to higher revenue and gross margins across the business Net income increased to $114,800 from $52,600 in Q1’20 which benefitted from $47,000 of accrued state taxes that were not payable Cash increased $0.5M to $1.7M at 3/31/21 versus a year ago Book value rose over $0.7M versus year-ago to $3.5MNocopi Chairman and CEO Michael...

Continue reading

Baltic Horizon Fund publishes its NAV for April 2021

The net asset value (NAV) of Baltic Horizon Fund (the Fund) unit at end of April 2021 amounted to EUR 1.1422 per unit. Compared to the previous month, NAV per unit decreased by -0.33%. The NAV decrease was mainly affected by declared distribution to unitholders of EUR 1.3 million. Eliminating declared dividend distribution, the NAV increase from operating performance during the month would have been +0.63% compared to the previous month. EPRA NRV as of 30 April 2021 was EUR 1.2241 per unit, corresponding to a decrease of -0.35% over the last month. The total net asset value of the Fund was EUR 136.7 million at the end of April 2021. Consolidated net rental income for April 2021 amounted to EUR 1.5 million, corresponding to a net rental income increase of EUR 0.1 million compared to the previous month (EUR 1.4 million in March 2021) due...

Continue reading

Baltic Horizon Fund publishes its NAV for April 2021

The net asset value (NAV) of Baltic Horizon Fund (the Fund) unit at end of April 2021 amounted to EUR 1.1422 per unit. Compared to the previous month, NAV per unit decreased by -0.33%. The NAV decrease was mainly affected by declared distribution to unitholders of EUR 1.3 million. Eliminating declared dividend distribution, the NAV increase from operating performance during the month would have been +0.63% compared to the previous month. EPRA NRV as of 30 April 2021 was EUR 1.2241 per unit, corresponding to a decrease of -0.35% over the last month. The total net asset value of the Fund was EUR 136.7 million at the end of April 2021. Consolidated net rental income for April 2021 amounted to EUR 1.5 million, corresponding to a net rental income increase of EUR 0.1 million compared to the previous month (EUR 1.4 million in March 2021) due...

Continue reading

NeuBase Therapeutics to Participate in Upcoming Investor Conferences in May 2021

RBC Capital Markets Virtual Global Healthcare Conference Fireside Chat at 11:30 a.m. ET on May 19 Oppenheimer Rare & Orphan Disease Summit presentation on May 21 PITTSBURGH, May 14, 2021 (GLOBE NEWSWIRE) — NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase”), a biotechnology company accelerating the genetic revolution with a new class of precision genetic medicines, announced today that Dietrich A. Stephan, Ph.D., Chief Executive Officer of NeuBase, will participate in a virtual fireside chat at the RBC Capital Markets Virtual Global Healthcare Conference, as well as present a corporate overview and business update at the Oppenheimer Rare & Orphan Disease Summit, which are both being held in May 2021. Conferences Details:Event: RBC Capital Markets Virtual Global Healthcare ConferenceFormat: Fireside ChatDate: Wednesday,...

Continue reading

Eva Soley Gudbjornsdottir resigns as Chief Financial Officer

Eva Soley Gudbjornsdottir, has asked to step down from her role as Chief Financial Officer of Icelandair Group. Eva Soley joined Icelandair Group early 2019 and has since then been instrumental in the Company’s efforts through unprecedented challenges, such as the extensive financial restructuring last year which was finalized with a successful share offering. Furthermore, Eva Soley has led the complete re-organization of the Company’s finance division.  Ivar S. Kristinsson has been appointed interim Chief Financial Officer of Icelandair Group and joins the Company’s Executive Committee with immediate effect. Ivar has in recent years held various leadership positions at Icelandair, i.e. as Chief Fleet and Network Officer, and prior to that as Director within Finance. He was the Director of Operations at Promens in 2006-2008, after having...

Continue reading

LGBTQ100 ESG Index Reconstituted Ahead of LGBTQ + ESG100 ETF Launch

The Index is reconstituted annually and added 11 new companies in March WEST HOLLYWOOD, Calif., May 14, 2021 (GLOBE NEWSWIRE) — LGBTQ Loyalty Holdings, Inc. (OTC PINK: LFAP) (“LGBTQ Loyalty” or “the Company”), a diversity- and inclusion-driven financial methodology and data company, announces through its wholly owned subsidiary, Loyalty Preference Index, Inc., the reconstitution of its LGBTQ100 ESG Index (Ticker: LGBTQ100). The environmental, social and governance (“ESG”) Index, launched in October 2019, is the first-ever Index that references LGBTQ community survey data in the methodology for a benchmark listing of the nation’s highest financially performing companies that respondents believe are most committed to advancing equality.  The Index is reconstituted annually and comprises 100 LGBTQ equality-driven...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.